Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/Mcl (ADVANZ-3)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Juan A. Arnaiz, Hospital Clinic of Barcelona
ClinicalTrials.gov Identifier:
NCT00532168
First received: September 18, 2007
Last updated: February 21, 2013
Last verified: February 2013